GSK Advisory: Warehouse Theft of Advair

GlaxoSmithKline is advising that two lots of Advair Diskus medication were stolen from the company’s distribution facility near Richmond, Virginia on August 2nd. The stolen medicine, could represent a health risk because it has been removed from the legitimate supply chain and storage conditions. Inhalers from these lots should not be dispensed, sold or used.

The lot numbers and quantities are:

• Lot 9ZP2255 - NDC 0173-0696-00, Advair Diskus 250/50, 60 Dose (14,400 inhalers)
• Lot 9ZP3325 - NDC 0173-0697-00, Advair Diskus 500/50, 60 Dose (11,200 inhalers)

These lots were awaiting distribution to retail pharmacies at the time of the theft. Neither of these lots are part of the legitimate pharmaceutical supply chain. GSK has alerted its distributors and customers to the stolen lots.

Anyone who has information regarding this incident, has received suspicious or unsolicited offers for the Advair Diskus lots in question, or has received product from these lots is encouraged to contact the U.S. Food and Drug Administration (FDA) Office of Criminal Investigations at 1-800-551-3989. Patient or customer inquiries for the company should be directed to GSK's Customer Response Center at 1-888-825-5249.

GSK discourages patients from purchasing any medication sold outside of legitimate channels.

XStream Systems encourages all members of the pharmaceutical supply chain to use pedigrees and authenticate their receiving and returns by using authentication technologies like the XT250 system which verifies materials inside its sealed unit-of-sale container without destroying or degrading the medication.

To view entire article click here.